Indefinite Delivery Contract 36E79720D0037
Award Date
7/1/20
Last Date to Order
6/30/25
Federal Agency
National Acquisition Center
Awardee
Marlex Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor, for the procurement of Baclofen tablets in various strengths and package sizes. The unrestricted, five-year IDC (1-year base, 4 one-year option periods) has a ceiling value of $7,305,230.02 and serves multiple federal healthcare agencies including the VA, Department of...
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Marlex Pharmaceuticals Inc. to supply probenecid 500mg tablets with a potential value of $5.4 million over a five-year base period and four option years. Place of performance will be in New Castle, Delaware. No set-aside was applied to the original pre-solicitation notice seeking annual supplies of approximately 18,719 bottles of probenecid tablets to support healthcare...
The Department of Veterans Affairs National Acquisition Center has awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business, to supply methocarbamol tablets over a one-year base period and four one-year option periods. The contract has a total ceiling value of $11,608,273.60 and will support the VA's Consolidated Mail Outpatient Pharmacy (CMOP) program as well as the VA, Department of Defense, Bureau of Prisons,...
The Federal Supply Schedule contract award to Marlex Pharmaceuticals Inc. is a multi-award indefinite delivery vehicle (IDV) with a ceiling value of $88,000,000 and a period of performance through February 1, 2030. The contract is administered by the Department of Veterans Affairs (VA) and covers a wide range of generic pharmaceutical and medical products, including medications such as haloperidol, prednisone, methocarbamol, loratadine, cetirizine, clonidine, gabapentin, and acetaminophen. As...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Marlex Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The contract, valued at $14,155,681.05, is for the supply of ezetimibe tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The period of performance is one year with four one-year option periods, running from April 28, 2024 to...
The federal contract IDV award provides for the supply of Ropinirole HCL tablets in various dosages to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single award contract, valued at $14,787,656.00, was granted to Marlex Pharmaceuticals Inc., a minority-owned, small disadvantaged business, for a one-year base period with four one-year option periods. Marlex will deliver the medications through the VA's...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Marlex Pharmaceuticals Inc., a minority-owned and self-certified small disadvantaged business manufacturer of generic pharmaceutical and medical products. The $5.7 million contract covers the supply of alendronate tablets in different sizes to support the medical needs of the VA, Bureau of Prisons, and Indian Health Service. The contract has...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract, valued up to $10,813,880, to Radha Pharmaceuticals Inc., a minority-owned small business manufacturer, to provide Carbidopa/Levodopa sustained-action tablets. The contract has a base period of one year from May 23, 2025 to May 22, 2026, with four one-year option periods. The contract aims to secure an uninterrupted supply of these pharmaceutical products for the VA, Department...
The National Acquisition Center, a civilian agency of the U.S. federal government, has awarded a single-award Indefinite Delivery Contract (IDC) to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The $761,850 contract is for the supply of lacosamide injections to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a one-year base period with four one-year option periods. This IDC was competitively awarded without any...
The provided information describes a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Marlex Pharmaceuticals Inc., a minority-owned small disadvantaged business. The contract (36F79719D0161) is for the provision of pharmaceuticals and medical products under Schedule 65 I B, covering a wide range of generic drugs such as antibiotics, pain relievers, allergy treatments, muscle relaxants, and cardiovascular medications. The contract has a ceiling...